Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbbVie Inc (ABBV) vs Roundhill Magnificent Seven ETF (MAGS) Price & Performance

AbbVie IncTrade
Roundhill Magnificent Seven ETFTrade

Price performance (Past 24H)

Key statistics

AbbVie Inc vs Roundhill Magnificent Seven ETF — how do they compare? AbbVie Inc trades at $248.12 (market cap $441.94B), while Roundhill Magnificent Seven ETF trades at $68.66. The key difference: AbbVie Inc pays a 2.77% dividend while Roundhill Magnificent Seven ETF pays none. Which is the better fit depends on your goals.

ABBVMAGS
Market Cap
$441.94B
Sector
HealthSector/Thematic
52-Week High
$263.58$70.94
52-Week Low
$197.38$55.39
Enterprise Value
$506.19B
Dividend Yield
2.77%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbbVie Inc

AbbVie (ABBV) trades at $247.91, up 0.76% today, with a bullish technical signal and strong analyst support. Recent earnings beats and a 70.73% buy consensus highlight robust fundamentals, driven by Skyrizi and Rinvoq growth offsetting Humira declines. Positive news includes Phase 2 ovarian cancer data and institutional stake increases, reinforcing momentum.

Outlook remains positive with a $278.69 price target, though risks include patent cliffs and debt levels. Revenue growth and dividend stability offer appeal, but investors should monitor competitive pressures and regulatory developments for sustained performance.

Roundhill Magnificent Seven ETF

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbbVie Inc

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Read more on ABBV

About Roundhill Magnificent Seven ETF

MAGS is an ETF that provides concentrated exposure to the seven technology-focused mega-cap companies often referred to as the 'Magnificent Seven' (Alphabet, Amazon, Apple, Meta, Microsoft, NVIDIA, and Tesla). The fund is designed to capture the performance of these market-leading stocks, which have been the primary drivers of market returns. It offers a simple way for investors to invest solely in this select group of high-growth technology companies.

Read more on MAGS